Vernon Sondak is a General Surgeon in Tampa, Florida. Dr. Sondak is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Neuroendocrine Tumor, Adult Soft Tissue Sarcoma, and Lymphadenectomy. Dr. Sondak is currently accepting new patients.

Rodabe Amaria is an Oncologist and a Hematologist in Houston, Texas. Dr. Amaria is rated as an Elite provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, and Metastatic Brain Tumor.

Craig Slingluff is a Surgical Oncologist in Charlottesville, Virginia. Dr. Slingluff is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Eccrine Porocarcinoma, Neuroendocrine Tumor, and Tissue Biopsy.

Amod Sarnaik is a General Surgeon and a Surgical Oncologist in Tampa, Florida. Dr. Sarnaik is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Neuroendocrine Tumor, Lymphofollicular Hyperplasia, and Lymphadenectomy. Dr. Sarnaik is currently accepting new patients.

Anthony Olszanski is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Olszanski is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma.

Joseph Clark is a Hematologist Oncology specialist and a Hematologist in Maywood, Illinois. Dr. Clark is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Nasopharyngeal Carcinoma, Bone Marrow Aspiration, and Gastrostomy. Dr. Clark is currently accepting new patients.

Eric Whitman is a General Surgeon and a Surgical Oncologist in Morristown, New Jersey. Dr. Whitman is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Pancreatic Cancer, Hyperparathyroidism, and Familial Pancreatic Cancer.

Michael Postow is a Dermatologist in New York, New York. Dr. Postow is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Uveal Melanoma, Sinus Cancer, Metastatic Uveal Melanoma, and Liver Embolization.

David Mcdermott is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Mcdermott is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Melanoma, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy.

Brian Gastman is a Plastic Surgeon in Cleveland, Ohio. Dr. Gastman is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Angiosarcoma of the Scalp, Tissue Biopsy, and Osteotomy.

Lynn Schuchter is an Oncologist in Philadelphia, Pennsylvania. Dr. Schuchter has been practicing medicine for over 44 years and is rated as an Elite provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Melanoma of the Eye, Squamous Cell Skin Carcinoma, and Merkel Cell Carcinoma. Dr. Schuchter is currently accepting new patients.

Susan Swetter is a Dermatologist in Palo Alto, California. Dr. Swetter is rated as an Elite provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Familial Atypical Multiple Mole Melanoma Syndrome, Syringocystadenoma Papilliferum, Sebaceous Adenoma, and Tissue Biopsy.

Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Metastatic Uveal Melanoma, Squamous Cell Skin Carcinoma, and Pancreaticoduodenectomy.

Ravi Amaravadi is an Oncologist in Philadelphia, Pennsylvania. Dr. Amaravadi is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Colorectal Cancer, Tissue Biopsy, and Liver Embolization. Dr. Amaravadi is currently accepting new patients.

Takami Sato is an Oncologist in Philadelphia, Pennsylvania. Dr. Sato is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Liver Embolization, and Osteotomy. Dr. Sato is currently accepting new patients.

Hensin Tsao is a Dermatologist in Boston, Massachusetts. Dr. Tsao is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Familial Atypical Multiple Mole Melanoma Syndrome, Squamous Cell Skin Carcinoma, and Basal Cell Skin Cancer.

Stanley Leong is a General Surgeon in San Francisco, California. Dr. Leong is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Adult Soft Tissue Sarcoma, Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, and Lymphadenectomy. Dr. Leong is currently accepting new patients.

Marlana Orloff is an Oncologist in Philadelphia, Pennsylvania. Dr. Orloff has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Melanoma, and Liver Embolization. Dr. Orloff is currently accepting new patients.

Dr. William H. Sharfman is an associate professor of oncology and dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous oncology, dermatology and immunotherapy. He helped create the well-established Melanoma Program at the Johns Hopkins Kimmel Cancer Center in 1994. Dr. Sharfman serves as the director of cutaneous oncology and clinical co-director for oncology at the Johns Hopkins Melanoma Program. He earned his M.D. from the University of Toledo College of Medicine. He completed his residency at Cleveland Clinic and performed a fellowship in hematology and oncology at Cleveland Clinic. Dr. Sharfman's research interests include novel therapies for high risk and advanced melanoma patients. Dr. Sharfman is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Eccrine Porocarcinoma, and Pancreatic Cancer.

Asim Amin is an Oncologist in Charlotte, North Carolina. Dr. Amin is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Melanoma, WT1-Related Wilms Tumor Syndromes, and Clear Cell Sarcoma. Dr. Amin is currently accepting new patients.